| Literature DB >> 15269951 |
Declan Sheppard1, Lynsay Allan, Pat Martin, Trudy McLeay, Wendy Milne, J Graeme Houston.
Abstract
Mangafodipir, a manganese-containing hepatobiliary contrast agent, is excreted in bile. We review the principles and practice of a contrast-enhanced MRC technique using mangafodipir and compare it with standard T2-weighted magnetic resonance cholangiography (MRC) sequences. Potential applications include the evaluation of leaks and strictures; the assessment of drainage in normal, surgically by-passed, stented and obstructed biliary systems; the diagnosis of cholecystitis; and the evaluation of normal and variant biliary anatomy. Copyright 2004 Wiley-Liss, Inc.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15269951 DOI： 10.1002/jmri.20114
Source DB: PubMed Journal: J Magn Reson Imaging ISSN： 1053-1807 Impact factor: 4.813